IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

USP Adopts New Manufacturing Controls for Heparin

2:13 AM MDT | October 2, 2009 | Deepti Ramesh

The United States Pharmacopeia (USP; Rockville, MD), a standards-setting organization, adopted new manufacturing controls for anti-clotting drug heparin, to ensure the quality of heparin and to guard against potential contamination, the U.S. FDA says. This follows several incidents of contamination of heparin in 2008. The FDA was criticized last year for its failure to inspect a plant in China that manufactured the API for heparin, which was cited as the cause of deaths and harmful effects in some U.S. patients. The revised standards for heparin are contained in...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa